Cialis Dosage Options and Strengths

Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g. passive holding) could represent bad faith use of a domain name under certain circumstances.� The decision noted that the determination as to what circumstances constituted "certain circumstances" worthy of a bad faith determination would be fact specific to each case.� In Telstra, some of the particular circumstances leading to a finding of bad faith included: (1) complainant's mark had a strong reputation and was widely known; (2) respondent failed to show any evidence of actual or contemplated good faith use by it of the domain name; and (3) it was impossible to conceive of any plausible actual or contemplated active use of the domain name by respondent that would not be illegitimate, such as being a passing off, an infringement of consumer protection legislation, or trademark infringement.� Such factors are present in the case at hand.� As set forth in detail above, Complainant's CIALIS mark has a strong reputation and is widely known throughout the world.� In addition, Respondents have no apparent rights cialis daily generic or legitimate interest in the Domain Names.� As described above, Respondents are using Complainant's CIALIS trademark in other domain names to attract Internet consumers to its websites, which are online pharmacies advertising and selling counterfeit versions of Complainant�s CIALIS brand product in violation of Complainant�s intellectual property rights and various national laws concerning the sale of pharmaceuticals.� With respect to the few �inactive� Domain Names, there is no plausible use of the associated websites by Respondents that would not be illegitimate.� Respondents� registration of multiple domain names which incorporate Complainant's distinctive CIALIS mark further demonstrates Respondents� improper conduct.� In light of these factors, Respondents' "passive holding" of some of the Domain Names amounts to use in bad faith. Moreover, as previous Panels have held, "rights or legitimate interests cannot be created where the user of the domain name at issue would not choose such a name unless he was seeking to create an impression of association with the complainant." See Eli Lilly and Company v. media/broadcasting, Lee Shung, D2010-1079 (WIPO, September 14, 2010) (determining that the respondent did not have any right or legitimate interest in the domain <36cialis.com> where the respondent sold unauthorized or counterfeit products of the complainant).� Respondents clearly chose the Domain Names in order to create an impression of association with Complainant and Complainant's well-known CIALIS mark.� In light of these factors, it is apparent from the websites associated with the Domain Names that the Respondents are attempting to capitalize on the valuable reputation and goodwill of the CIALIS mark to direct Internet users to its websites.�� � ���(2)� Respondents are not authorized by Complainant to use the CIALIS trademark.

• Always check for proper labeling at the pharmacy.
• Generic versions of Cialis may be available.
• Discuss potential side effects with your doctor.
• Report persistent erections lasting over 4 hours.
• Cialis can improve quality of life for those with ED.
• Do not take Cialis if you're on certain blood thinners.
• Use Cialis only as directed by your healthcare provider.
• Cialis is not an aphrodisiac and requires arousal.
• Be aware of possible interactions with other drugs.
• Avoid combining Cialis with alcohol excessively.
• Store Cialis away from heat and humidity.
• Seek immediate medical help if adverse reactions occur.

Complainant has not given Respondents permission, authorization, consent or license to use its CIALIS mark.� Despite this fact, however, the Domain Names resolve to websites enabling the Respondents to benefit from the strength of Complainant's CIALIS mark and the reputation and goodwill of the product with which the mark is associated. [c.]��������� The Domain Names were registered and are being used in bad faith. Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S.

🗣️ Patient Experience

Ozurls, D2001-0046 (WIPO, March 20, 2001) (finding that fifteen domain names that involved Telstra's mark and a series of services, products, geographical descriptors, or generic words obviously involves a pattern of conduct directed against Telstra, stopping it from reflecting its mark in corresponding domain names).� Such is the case here, where the Respondents registered over 70 Domain Names, all of which incorporate the Complainant's well-known and distinctive CIALIS mark.� Further, promoting competing products under another�s mark disrupts a trademark owner�s business and reveals bad faith registration and use according to Policy �4(b)(iii). See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011).� In this case, several of the websites associated with the Domain Names promote illegal, counterfeit pharmaceutical products, as well as competing products which demonstrates bad faith use and canadian pharmacy no prescription cialis registration pursuant to the Policy. Additionally, the Respondents are likely using Complainant's CIALIS mark in the Domain Names to drive Internet traffic to its websites and likely profiting from the purchase of any products from the associated online pharmacy.� Prior NAF Panels have noted that such activities create a likelihood of confusion as to the source, sponsorship or affiliation of the resolving websites, from which a respondent presumably profits and demonstrates bad faith registration and use according to Policy �4(b)(iv). See Eli Lilly and Company v.

Market Demand Trends

Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P).� Moreover, prior NAF Panels have found, �that the offer of counterfeit and competing products constitutes bad faith attraction for commercial gain under Policy �4(b)(iv).�� See Eli Lilly and Company v. Grace Beaumont et. One may argue that the Respondents� conduct with respect to 10 of the Domain Names that currently don�t have active websites cannot be said to come squarely within any of the examples of bad faith registration and use set out in �4(b) of the Policy. However, the examples in �4(b) are intended to be illustrative, rather than exclusive. See Telstra Corporation Limited v.

Pricing Information

Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000) (Annex 3, R). As discussed in detail above, the Telstra decision established that "inaction" can constitute bad faith use, and the decision has since been cited for that proposition and followed by many subsequent Panels. See Staples, Inc. v. Ryan canadian pharmacy cialis 20mg Conrad, D2003-0713 (WIPO, October 27, 2003) (Annex 3, V). trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v. Darren K. Headley et al., D2103-1303 (WIPO, September 4, 2013) (registering 10 domain names incorporating the CIALIS mark demonstrated that the respondent registered and was using the disputed domain names in bad faith per paragraph 4(b)(ii)).� Moreover, prior Forum Panels found that the registration of multiple domains incorporating the Complainant�s CIALIS mark revealed bad faith registration and use pursuant to Policy �4(b)(ii).� See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P) and Eli Lilly and Company v. Grace Beaumont et. al, FA1504001615093 (NAF, June 5, 2015).� In this case, the Respondents have registered over 70 domains which incorporate the Complainant's CIALIS mark. Moreover, in order to establish a pattern of conduct, one need not demonstrate an impact against multiple trademark owners.� Instead, while a pattern of conduct typically involves multiple domain names directed against multiple complainants, it may involve multiple domain names directed against a single complainant.� See Telstra Corporation Limited v.

Product	Dosage	Quantity + Bonus	Price
Cialis Generic	10mg	120 + 6 Pills	178.49€ 169.99€	Buy
Cialis Generic	40mg	10 Pills	37.79€ 35.99€	Buy
Cialis Professional	20mg	30 Pills	104.57€ 99.59€	Buy
Cialis Black	80mg	60 + 4 Pills	150.98€ 143.79€	Buy
Cialis Generic	60mg	60 + 4 Pills	145.06€ 138.15€	Buy
Cialis Generic	40mg	120 + 8 Pills	206.98€ 197.12€	Buy
Cialis Super Active	20mg	90 + 10 Pills	314.14€ 299.18€	Buy
Cialis Generic	5mg	10 Pills	29.39€ 27.99€	Buy
Cialis Soft Tabs	20mg	10 Pills	39.03€ 37.17€	Buy
Cialis Professional	40mg	10 Pills	65.09€ 61.99€	Buy
Cialis Super Active	20mg	30 + 6 Pills	128.09€ 121.99€	Buy
Cialis Professional	20mg	120 + 4 Pills	291.68€ 277.79€	Buy
Cialis Generic	60mg	360 + 10 Pills	570.52€ 543.35€	Buy
Cialis Original	20mg	64 + 4 Pills	274.18€ 261.12€	Buy

Ozurls, D2001-0046 (WIPO, March 20, 2001) (finding that fifteen domain names that involved Telstra's mark and a series of services, products, geographical descriptors, or generic words obviously involves a pattern of conduct directed against Telstra, stopping it from reflecting its mark in corresponding domain names).� Such is the case here, where the Respondents registered over 70 Domain Names, all of which incorporate the Complainant's well-known and distinctive CIALIS mark.� Further, promoting competing products under another�s mark disrupts a trademark owner�s business and reveals bad faith registration and use according to Policy �4(b)(iii). See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011).� In this case, several of the websites associated with the Domain Names promote illegal, counterfeit pharmaceutical products, as well as competing products which demonstrates bad faith use and canadian pharmacy no prescription cialis registration pursuant to the Policy. Additionally, the Respondents are likely using Complainant's CIALIS mark in the Domain Names to drive Internet traffic to its websites and likely profiting from the purchase of any products from the associated online pharmacy.� Prior NAF Panels have noted that such activities create a likelihood of confusion as to the source, sponsorship or affiliation of the resolving websites, from which a respondent presumably profits and demonstrates bad faith registration and use according to Policy �4(b)(iv). See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P).� Moreover, prior NAF Panels have found, �that the offer of counterfeit and competing products constitutes bad faith attraction for commercial gain under Policy �4(b)(iv).�� See Eli Lilly and Company v. Grace Beaumont et. One may argue that the Respondents� conduct with respect to 10 of the Domain Names that currently don�t have active websites cannot be said to come squarely within any of the examples of bad faith registration and use set out in �4(b) of the Policy.

• Cialis’s onset is typically within 30 minutes.
• The drug’s effects can last up to 36 hours.
• Do not take more than the prescribed dose.
• Missed doses should not be doubled.
• Consult your doctor if you miss a dose.
• Cialis is not an instant solution; arousal is needed.
• Overuse can increase side effect risk.
• Ensure your doctor is aware of all health conditions.
• Cialis is used worldwide for ED treatment.
• Pharmacists provide guidance on safe use.
• Be mindful of expiration dates.
• Do not use expired medication.

However, the examples in �4(b) are intended to be illustrative, rather than exclusive. See Telstra Corporation Limited v. Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000) (Annex 3, R). As discussed in detail above, the Telstra decision established that "inaction" can constitute bad faith use, and the decision has since been cited for that proposition and followed by many subsequent Panels. See Staples, Inc.

Are There Alternative Names for the Brand and Generic Cialis?

As a result, Respondents' passive and misleading use of 10 of the Domain Names constitutes bad faith registration and use. "It is further important to state that the mere holding of a domain name that is identical or confusingly similar to a trademark belonging to someone else, prevents the holder of the said mark to be present on the Internet under a domain name that reflects the trademark, which in itself can be considered disrupting to his business. "� See Healthy Back LLC v. Ivo Somoza, D2003-0276 (WIPO, June 3, 2003).� Respondents' registration and misleading use of the Domain Names is disrupting to Complainant's business.� Finally, Respondents� use of Complainant's CIALIS mark in the Domain Names is potentially harmful to the health of many unsuspecting consumers who may purchase unlawfully sold pharmaceutical products promoted through the websites associated with the Domain Names under the mistaken impression that they are dealing with Complainant and, therefore, are receiving information on safe and effective drugs approved by the FDA or other health authorities around the world.� As discussed above, �Generic� CIALIS brand product has neither been developed by the Complainant nor approved by the FDA or any other health authority.� Complainant's CIALIS brand product is only available on a physician's prescription and is manufactured, labeled, and sold in strict compliance with the FDA and other health authority laws and regulations.� A prior panel has noted that the obvious danger of consumers being afforded inaccurate, incomplete or misleading information about medical products may further demonstrate a Respondent's bad faith.� See Eli Lilly and Company v. Ryma Nynyore/Domain Directors Pty.

Special Precautions

Ltd., D2011-0478 (WIPO, April 29, 2011).� In light of all of these factors, it is apparent that the Respondents have clearly registered and are using the Domain Names in bad faith.� Respondent failed to submit a Response in this proceeding. (1) the domain names registered by Respondent are identical or confusingly similar to a trademark or service mark in which Complainant has rights; and (2) Respondent has no rights or legitimate interests in respect of the domain names; and (3) the domain names were registered and are being used in bad faith.

Black Box Warnings

v.

Cialis Storage and Safety Information

Nuclear Marshmallows, D2000-0003 (WIPO, February 18, 2000), WIPO recognized that a respondent's inaction (e.g. passive holding) could represent bad faith use of a domain name under certain circumstances.� The decision noted that the determination as to what circumstances constituted "certain circumstances" worthy of a bad faith determination would be fact specific to each case.� In Telstra, some of the particular circumstances leading to a finding of bad faith included: (1) complainant's mark had a strong reputation and was widely known; (2) respondent failed to show any evidence of actual or contemplated good faith use by it of the domain name; and (3) it was impossible to conceive of any plausible actual or contemplated active use of the domain name by respondent that would not be illegitimate, such as being a passing off, an infringement of consumer protection legislation, or trademark infringement.� Such factors are present in the case at hand.� As set forth in detail above, Complainant's CIALIS mark has a strong reputation and is widely known throughout the world.� In addition, Respondents have no apparent rights cialis daily generic or legitimate interest in the Domain Names.� As described above, Respondents are using Complainant's CIALIS trademark in other domain names to attract Internet consumers to its websites, which are online pharmacies advertising and selling counterfeit versions of Complainant�s CIALIS brand product in violation of Complainant�s intellectual property rights and various national laws concerning the sale of pharmaceuticals.� With respect to the few �inactive� Domain Names, there is no plausible use of the associated websites by Respondents that would not be illegitimate.� Respondents� registration of multiple domain names which incorporate Complainant's distinctive CIALIS mark further demonstrates Respondents� improper conduct.� In light of these factors, Respondents' "passive holding" of some of the Domain Names amounts to use in bad faith. Moreover, as previous Panels have held, "rights or legitimate interests cannot be created where the user of the domain name at issue would not choose such a name unless he was seeking to create an impression of association with the complainant." See Eli Lilly and Company v. media/broadcasting, Lee Shung, D2010-1079 (WIPO, September 14, 2010) (determining that the respondent did not have any right or legitimate interest in the domain <36cialis.com> where the respondent sold unauthorized or counterfeit products of the complainant).� Respondents clearly chose the Domain Names in order to create an impression of association with Complainant and Complainant's well-known CIALIS mark.� In light of these factors, it is apparent from the websites associated with the Domain Names that the Respondents are attempting to capitalize on the valuable reputation and goodwill of the CIALIS mark to direct Internet users to its websites.�� � ���(2)� Respondents are not authorized by Complainant to use the CIALIS trademark. Complainant has not given Respondents permission, authorization, consent or license to use its CIALIS mark.� Despite this fact, however, the Domain Names resolve to websites enabling the Respondents to benefit from the strength of Complainant's CIALIS mark and the reputation and goodwill of the product with which the mark is associated.

Side Effects

[c.]��������� The Domain Names were registered and are being used in bad faith. Complainant has a June 17, 1999 constructive use date of the CIALIS trademark based upon its U.S. trademark rights.� Media coverage of the CIALIS brand product is dated as early as 2001.� Complainant has extensively marketed and advertised its pharmaceutical product using the CIALIS trademark.� Therefore, because it is reasonable to infer that the CIALIS trademark is well-known, it is highly likely that the Respondents knew of Complainant's CIALIS mark at the time of registering over 70 confusingly similar Domain Names. According to Policy �4(b)(ii), evidence of bad faith registration and use is shown when a respondent has registered a domain name in order to prevent the trademark owner from reflecting the mark in a corresponding domain name, provided the respondent has engaged in a pattern of such conduct.�� See Eli Lilly and Company v. Darren K.

Feedback from Forums

Headley et al., D2103-1303 (WIPO, September 4, 2013) (registering 10 domain names incorporating the CIALIS mark demonstrated that the respondent registered and was using the disputed domain names in bad faith per paragraph 4(b)(ii)).� Moreover, prior Forum Panels found that the registration of multiple domains incorporating the Complainant�s CIALIS mark revealed bad faith registration and use pursuant to Policy �4(b)(ii).� See Eli Lilly and Company v. Igor Palchikov, FA 1105001388612 (NAF, June 15, 2011) (Annex 3, P) and Eli Lilly and Company v. Grace Beaumont et. al, FA1504001615093 (NAF, June 5, 2015).� In this case, the Respondents have registered over 70 domains which incorporate the Complainant's CIALIS mark. Moreover, in order to establish a pattern of conduct, one need not demonstrate an impact against multiple trademark owners.� Instead, while a pattern of conduct typically involves multiple domain names directed against multiple complainants, it may involve multiple domain names directed against a single complainant.� See Telstra Corporation Limited v. Ryan canadian pharmacy cialis 20mg Conrad, D2003-0713 (WIPO, October 27, 2003) (Annex 3, V). As a result, Respondents' passive and misleading use of 10 of the Domain Names constitutes bad faith registration and use.

• The future of ED treatment may include new formulations like rapidly dissolving tablets or creams.
• Research is ongoing into stem cell therapy and gene therapy as potential long-term solutions.
• The field of telemedicine is expected to continue growing, improving access to ED consultations.
• Artificial intelligence may eventually be used to help personalize treatment plans based on big data.
• Despite advances, the foundation of treatment will remain a combination of lifestyle changes and medicine.
• Patient education is paramount for the safe and effective use of any medication, including Cialis.
• Understanding how the drug works, its benefits, and its risks empowers you to be an active participant.
• Reliable sources of information include your doctor, pharmacist, and official health organization websites.
• Be skeptical of sensationalized claims or "miracle cures" advertised online or elsewhere.
• A trusted healthcare team is your best resource for managing your health and treatment successfully.

"It is further important to state that the mere holding of a domain name that is identical or confusingly similar to a trademark belonging to someone else, prevents the holder of the said mark to be present on the Internet under a domain name that reflects the trademark, which in itself can be considered disrupting to his business. "� See Healthy Back LLC v. Ivo Somoza, D2003-0276 (WIPO, June 3, 2003).� Respondents' registration and misleading use of the Domain Names is disrupting to Complainant's business.� Finally, Respondents� use of Complainant's CIALIS mark in the Domain Names is potentially harmful to the health of many unsuspecting consumers who may purchase unlawfully sold pharmaceutical products promoted through the websites associated with the Domain Names under the mistaken impression that they are dealing with Complainant and, therefore, are receiving information on safe and effective drugs approved by the FDA or other health authorities around the world.� As discussed above, �Generic� CIALIS brand product has neither been developed by the Complainant nor approved by the FDA or any other health authority.� Complainant's CIALIS brand product is only available on a physician's prescription and is manufactured, labeled, and sold in strict compliance with the FDA and other health authority laws and regulations.� A prior panel has noted that the obvious danger of consumers being afforded inaccurate, incomplete or misleading information about medical products may further demonstrate a Respondent's bad faith.� See Eli Lilly and Company v.

Prescription Refills

Ryma Nynyore/Domain Directors Pty. Ltd., D2011-0478 (WIPO, April 29, 2011).� In light of all of these factors, it is apparent that the Respondents have clearly registered and are using the Domain Names in bad faith.� Respondent failed to submit a Response in this proceeding.

Question	Answer
How long does Cialis last?	Up to 36 hours
Can I drink alcohol with Cialis?	Moderate alcohol is generally safe, but excessive drinking may reduce effectiveness and increase side effects
Is Cialis safe for women?	No, approved only for men
Can I take Cialis daily?	Yes, in prescribed low doses

(1) the domain names registered by Respondent are identical or confusingly similar to a trademark or service mark in which Complainant has rights; and (2) Respondent has no rights or legitimate interests in respect of the domain names; and (3) the domain names were registered and are being used in bad faith.